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Human life is unlimited – but short
Holger Rootze´n∗ and Dmitrii Zholud†
Abstract
Does the human lifespan have an impenetrable biological upper limit which ultimately will stop
further increase in life lengths? This question is important for understanding aging, and for society,
and has led to intense controversies. Demographic data for humans has been interpreted as showing
existence of a limit, or even as an indication of a decreasing limit, but also as evidence that a limit
does not exist. This paper studies what can be inferred from data about human mortality at
extreme age. We show that in western countries and Japan and after age 110 the probability of
dying is about 47% per year. Hence there is no finite upper limit to the human lifespan. Still,
given the present stage of biotechnology, it is unlikely that during the next 25 years anyone will live
longer than 128 years in these countries. Data, remarkably, shows no difference in mortality after
age 110 between sexes, between ages, or between different lifestyles or genetic backgrounds. These
results, and the analysis methods developed in this paper, can help testing biological theories of
ageing and aid confirmation of success of efforts to find a cure for ageing.
Keywords: Extreme human life lengths; no influence of lifestyle on survival at extreme age; no influence of
genetic background on survival at extreme age; future record ages; supercentenarians; Jeanne Calment; limit
for human life span; force of mortality; size-biased sampling; generalized Pareto distribution.
1 Does the human lifespan have a finite limit?
Inferences about mortality at extreme age crucially depend on the quality of data, and on analysis
respecting the way data has been collected. Bad data or wrong analysis can, and has, led to mislead-
ing conclusions, and also good analyses become outdated when more informative data is collected.
Conclusions about a limit for the human lifespan are only meaningful if they are accompanied by a
clear definition of the concept of a limit for the random variation of lifespans of individuals. They
have led to intense controversies (Couzin-Frankel, 2011).
A recent Nature Letter, Dong et al. (2016), claims that “the maximum lifespan of humans is fixed
and subject to natural constraints”. The claim rests on plots showing that the rate of improvement in
survival is slower at very high ages; the observation that annual average age at death of supercente-
narians (humans who are more than 110 years old) has not changed; and on analysis of the yearly
highest to the fifth highest reported age at death. However, a slower rate of improvement is still an
improvement, and, if anything, it contradicts the existence of a limit. Further, record age will increase
as more supercentenarians are observed, even if the distribution of their life lengths does not change.
Finally, the analysis of the yearly highest reported ages of death is misleading. Thus the conclusion
∗Department of Mathematical Statistics
Chalmers University of Technology and University of Go¨teborg, Sweden.
E-mail: hrootzen@chalmers.se
†Department of Mathematical Statistics
Chalmers University of Technology and University of Go¨teborg, Sweden.
E-mail: dmitrii@chalmers.se
ar
X
iv
:1
70
8.
02
18
4v
1 
 [s
tat
.A
P]
  7
 A
ug
 20
17
Holger Rootze´n and Dmitrii Zholud
in Dong et al. (2016) is unfounded and based on inappropriate use of statistics. Additional details are
given in Section 4.
A similar claim that there is a “biologic barrier limiting further life-span progression” is made in
Antero-Jacquemin et al. (2015). The claim is based on analysis methods which do not distinguish
between a finite and an infinite limit, which do not take truncation caused by sampling scheme
into account (see discussion below), and which sometimes exclude the most extreme life lengths from
analysis. Neither of the papers Dong et al. (2016) or Antero-Jacquemin et al. (2015) define the concept
of a limit for the human lifespan.
Earlier papers, (Weon and Je, 2009, Aarssen and de Haan, 1994, Wilmoth et al., 2000), argue both
for and against a limit for the human lifespan. The arguments are based on analysis of data from the
Netherlands or Sweden with maximum recorded ages 112 years or less. Extrapolation to conclusions
about the existence, or not, of a limit of 122.45 or more years, the age of the longest living documented
human, Jeanne Calment, are long, and thus uncertain.
In a careful analysis Gampe (2010) studies survival after age 110 using non-parametric EM esti-
mates in a life-table setting. Her results agree with the present paper and hence, specifically, provide
important confirmation that the parametric models we use are appropriate. However our parametric
approach makes a much more detailed analysis possible, and, in particular, addresses the question
of a limit for the human lifespan; make predictions about future record ages possible; and makes it
possible to perform tests and to obtain reasonable confidence intervals. There is some consensus that
“the notion of an intractable species-specific senescent death and species-specific maximum lifespan”
has been refuted (Vaupel, 2010).
To summarize, the question if there is a limit to the human lifespan still has not received any
convincing answer. In this paper we use the best available data, the International Database on
Longevity (IDL, 2016) to give the currently best possible answer to the question, and to study how
factors such as gender, age, lifestyle, or genetic background change - or do not change - human
mortality at extreme age. We use statistical Extreme Value Theory which is the appropriate statistical
framework for study of extreme ages.
Unvalidated data on ages of supercentenarians is known to be completely unreliable (Poulain,
2010). The IDL database contains validated life lengths of 668 supercentenarians from 15 countries,
with “data collection performed in such a way that age-ascertainment bias is avoided”. This means
that validation was performed with equal effort for younger and older supercentenarians. The only
other data on validated lifespans of supercentenarians, the GRG (2016) list, does not have a clearly
specified plan for data collection, and is expected to be agebiased.
The sampling scheme in the IDL database is somewhat different for different countries, but typically
IDL contains ages of persons who died in some time interval, say 1980-1999, at age exceeding 110 years.
The time intervals are different for different countries. This sampling scheme leads to both left and
right truncation of life lengths. The analysis in this paper throughout takes this truncation into
account; for details see Section 3.3. This is important: analysis which does not do this properly would
lead to crucially different results.
Extreme value statistics provides methods for analysis of the most extreme parts of data: extreme
floods, extreme winds, extreme financial events – or extreme life lengths, here excess life length after
age 110. The generalized Pareto (GP) distribution plays the same role for analysis of extreme excesses
as the Gaussian distribution does in other parts of statistics (Coles, 2001, Beirlant et al., 2004).
We summarize the main results of the analysis in Section 2. Details on data and statistical analysis
are given in Section 3, and comments on the Dong et al. (2016) paper in Section 4. Section 5 contains
a concluding discussion.
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2 The human lifespan is unbounded, but short
Our aim is to estimate the “force of mortality” at extreme age. The force of mortality, or hazard
rate, is the instantaneous rate of mortality so that, e.g., (assuming the measurement unit is year)
the probability of dying tomorrow is 1/365 times the force of mortality today. Formally, the force of
mortality equals minus the derivative of the log survival function (here again with survival measured
in years). We model excess life length (life length minus 110 years) of supercentenarians with a GP
distribution. The GP model includes three different cases with distinct behaviors of the force of
mortality. In the first case there is a finite age at which the force of mortality tends to infinity and
beyond which survival is not possible – in this case lifespans have a finite limit; in the second case
the force of mortality is constant – life is unlimited but short (more precisely, survival after age 110
is short); and in the third case the force of mortality decreases with age – life is unlimited. In the
second case excess life length has an exponential distribution. The three cases are illustrated in Fig. 1.
Additionally, Fig. 1 shows the importance of taking truncation caused by the sampling scheme into
account.
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Figure 1: Left: GP distribution fitted to IDL data for Japan, without taking truncation into account.
Life appears to have a finite limit equal to 116.0 years. Middle: Exponential distribution fitted to
all IDL data with validation level A, with truncation taken into account. Life is unlimited but short.
Right: GP distribution fitted to IDL data for France, without truncation taken into account. Life
appears to be unlimited. However, changing estimation for Japan and France so that truncation is
taken into account leads to the conclusion that, in fact, also in these countries life is unlimited but
short.
Likelihood ratio tests using the assumption of a GP distribution, or assuming an exponential
distribution, show that although around 10 times as many women as men live to age 110 years,
differences in mortality, if any, between women and men after age 110 are too small to be detectable
from the IDL data. Likelihood ratio tests also did not detect any difference in survival between south
and north Europe, between western Europe and north America, or between Japan and the other
countries. Wald tests did not identify any differences in mortality above age 110 for earlier and later
parts of the data, and likelihood ratio tests did not reject the hypothesis that survival after age 110
has an exponential distribution. The resulting model, that mortality after 110 years of age is constant,
fits the data well (Tables 2-5, Fig. 4).
Thus, our conclusion is that in western Europe, north America, and Japan excess human life
length after age 110 follows an exponential distribution – human life is unlimited, but short – and
that survival is the same for women and men, during earlier periods and later ones, and in countries
with very different lifestyles and genetic compositions. The mean of the exponential distribution was
estimated to be 1.34 with 95% confidence interval (1.22, 1.46). Survival after 110 in these countries
can hence be described as follows: each year a coin is tossed, and if heads comes up it means a person
will live one more year; more precisely, the estimated probability to survive one more year is 47%,
with 95% confidence interval (0.44, 0.50).
The number of persons who live longer than 110 years is rapidly increasing (Fig. 2). Still, it is a
very extreme event that a woman will live 110 years: the probability is only about 2 out of 100,000.
3 Copyright c© 2017 by Dmitrii Zholudwww.zholud.com
Holger Rootze´n and Dmitrii Zholud
For a man this probability is ten times smaller. Given an unchanged mortality after age 110 and a
continued increase in the number of supercentenarians, it is likely that the record age which will be
documented in western Europe, north America or Japan during the coming 25 years will exceed 119
years but will be shorter than 128 years (Fig. 3, Section 3.2). If the record falls outside this interval,
it would be an indication that survival has changed.
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Figure 2: Yearly number of deaths of validated supercentenarians from England and Wales, Italy, and
USA. Line is computed using Poisson regression with Left: identity link Right: log link.
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Figure 3: Probability density for record life length during 2018-2042 moves left if parameter σ of
exponential distribution, or the number of deaths of supercentenarians (n), are decreased, and to the
right if they are increased. Plots show estimated density of record life length (blue) together with
lower (green) and upper (red) bounding densities obtained by setting σ and n equal to the lower or
upper bounds in their confidence intervals. Parameter n is estimated using Poisson regression with
Left: identity link Right: log link.
Jeanne Calment lived 3.18 years longer than the second longest-living person in the IDL data,
which seems extreme, and could indicate that she is an “outlier”. Her life length is the longest of the
566 supercentenarians with validation level A, and the probability that the largest of 566 exponential
variables with mean 1.34 is larger that 12.45 (her excess life length, 122.45-110) is 5%. Thus there
is some evidence that her life length is close to being an outlier – or that, alternatively, mortality
decreases at extremely high age, say after age 118.
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3 Materials and Methods
3.1 International database on longevity
The IDL (2016) database contains validated supercentenarian life lengths from 15 countries. The
inclusion criterion typically is that the death has occurred in a specified time interval, however with
different time intervals for different countries, and with somewhat more complicated criteria for USA
and Japan. There are two validation levels, A and B, with level A being the most thorough validation.
In the analysis of the IDL data we only used the 566 life lengths with validation level A, and
countries were grouped geographically, and so that groups contain 64 or more supercentenarians, see
Table 1. The grouping was mandated by the fact that data from several countries included too few
supercentenarians to make it meaningful to analyse these countries separately.
Table 1: Data sets used for analysis. IDL data with validation level A. Persons who died after
December 31, 1999, in USA, or died in 1996 or after August 31, 2003, in Japan, are excluded.
ID consists of women men
North Europe Denmark, Germany, England and Wales 79 5
South Europe Italy, France, Spain 97 17
Europe North and south Europe 176 22
North America USA, Quebec 272 28
Japan Japan 55 9
Europe&America Australia, Europe, North America, 452 50
World Europe&America, Japan 507 59
We excluded persons who died after December 31, 1999 in the USA, and persons who died in
1996 or after August 31, 2003 in Japan; see Section 3.3 below. In the sequel we for brevity just write
“Europe&America” for the data set which contains countries from western Europe, north America,
and Australia, and “World” for the entire data set. To investigate the possibility of time trends in
mortality of supercentenarians the data sets were split into two parts according to year of death.
Except for World, the division was made so that the second part included more persons than the first
one, but with the difference between the number of persons in the parts as small as possible.
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Figure 4: IDL data with validation level A, from “”World”. Left: Life lengths against year of death:
blue - women, red - men, black - persons who died after December 31, 1999 in USA or in 1996 or after
August 31, 2003 in Japan and which are not included in analyses. Green square is Jeanne Calment.
Right: Exponential qq-plot.
Including the 32 persons in countries validated at level B (Belgium, Finland, Norway, Sweden,
Switzerland) in the analysis did not change conclusions. We also did the analyses reported below for
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life lengths in excess of higher age thresholds: 110.5, 111, 111.5, and 112 years. This did not change
any of the conclusions, although estimates of course were somewhat different, and confidence intervals
were wider for higher thresholds. The estimates and tests obtained after including validation level
B data and/or using higher thresholds are given by the MATLAB toolbox LATool which we have
developed and which is available as Supplementary Material. Similarly, removing the largest age,
Jeanne Calment’s age, from the data did not change conclusions.
3.2 Statistical analysis
The GP distribution has cumulative distribution function G(x) = 1 − (1 + γx/σ)−1/γ+ and force of
mortality function (1 + γx/σ)−1+ /σ, where + signifies that the expression in parentheses should be
replaced by zero if negative. Here γ is a shape parameter, termed the extreme value index, and σ is
a scale parameter. The three different cases, limited life length, unlimited but short life length, and
unlimited life length, correspond to γ < 0, γ = 0 and γ > 0, respectively.
The statistical analyses were done using LATool, the MATLAB toolbox which is available as
Supplementary Material. The toolbox uses maximum likelihood estimation which takes the truncation
caused by the sampling scheme into account, see Section 3.3. Confidence intervals were computed
using asymptotic normality. The two sets of p-values in Tables 2 and 4 correspond to the two possible
testing strategies: first test using the GP distribution, and then in the end test for γ = 0, i.e. for an
exponential distribution, or conversely start with testing for an exponential distribution and then do
the other tests assuming an exponential distribution. Both strategies lead to the same conclusions.
The probability to survive one more year is e−1/σ. Inserting the estimate and confidence limits for
σ into this formula gives the estimate and confidence interval for the yearly survival probability.
The maximum, or record, of n exponential random variables with parameter σ has cumulative
distribution function (1 − e−x/σ)n and probability density function ne−x/σ(1 − e−x/σ)n−1/σ. Hence,
to predict the size of the record age in some time period both the value of σ (estimated above) and
the value of n, the number of supercentenarians who will die in the period, is needed.
To estimate the trend in the number of supercentenarians using data from different countries, the
data must cover the same time period. Such data is available for for supercentenarians who died
in the time period 1980-1999, for the countries Italy, England and Wales, and USA. Using Poisson
regression with linear link function, the expected number of supercentenarians who will die in these
three countries during the next 25 years, i.e. in 2018-2042, was estimated to be 1,690 with a 95%
confidence interval (1,326, 2,054).
The ratio of the number of persons aged 100–104 in north America, western Europe and Japan1 in
the year 2000 in the Human Mortality Database (HMD, 2016) to the same number for Italy, England
and Wales, and USA is 1.76. We used this ratio, 1.76, as a proxy for the relative number of deaths
of supercentenarians in these countries. Multiplying the estimate and confidence interval with 1.76
gave the estimate n = 2, 974, with confidence interval (2,334, 3,615), for the expected number of
supercentenarians who will die in the period 2018-2042 in north America, western Europe and Japan.
Assuming independence of this interval and the 95% confidence interval for σ gives a joint confidence
level 90%.
The same computations using a log link (i.e. assuming an exponential growth of the number of
supercentenarians) in the Poisson regression gave the estimate n = 18, 717 with confidence interval
(7,429, 46,962) obtained by simulating parameter values from the limiting normal distribution. It may
be noted that these predictions only depend on changes in survival up to age 110 and are not affected
by future fluctuations in birth rates: all supercentenarians who will die in the interval 1918-1942 are
already born.
1Austria, Canada, Denmark, Belgium, France, Finland, Iceland, Ireland, Italy, Japan, the Netherlands, Norway,
Portugal, Spain, Sweden, UK, USA.
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Inserting x = age−110 and the estimates σ = 1.34, n = 2, 974 into the formula for the probability
density function for the record gives the blue graph in Fig. 3, left panel. Instead using the lower
confidence interval bounds σ = 1.22, n = 2, 334 gives a lower bound probability density function: this
is the green graph in Fig. 3, left. The upper bound, and the graphs in Fig. 3, right, are computed
similarly.
Using the formula for the cumulative distribution function of record age and the linear estimate of
n gives the estimate 3% for the probability that the record age is lower than 119. Instead inserting the
lower bounds of the confidence intervals into the formula gives the upper bound estimate 23% of the
probability. Similar computations, using the exponential growth estimate of n gives the estimate 3%
for the probability that the record age exceeds 128 years, and the upper bound 19% for this probability.
This shows that it is likely that the record age will fall in the interval 119-128 years. These results
are obtained assuming that present mortality and growth of number of supercentenarians remain
unchanged.
There are only 10 persons in the World data set who lived longer than 115 years, and hence little
data to confirm an exponential distribution beyond this age. Still these 10 data points are in agreement
with an exponential distribution (Fig. 4). In view of predictions of very rapid growth of the number
of centenarians (Thatcher, 2010), the results based on the exponential regression for n may capture
the most likely development.
In the computations above we for simplicity of exposition used the expected rather than actual,
random, number of supercentenarians. However, assuming a Poisson distribution with mean n for the
number N of supercentenarians who die in 2018-2042, the distribution of the record age is
P (MN ≤ x) = E(P (MN ≤ x|N)) = E((1− e−x/σ)N )
= en{(1−e
−x/σ)−1} = e−ne
−x/σ
.
It can be seen by numerical computation that for the parameter values used above the difference
between this expression and (1− e−x/σ)n is less than one unit in the second decimal. The same holds
for the densities obtained by differentiation of the two formulas.
3.3 The IDL sampling scheme: left and right truncation
The two exponential qq-plots in Figure 5 are quite different, and illustrates that the sampling scheme
has to be taken into account in the analysis. Specifically, the explanation of the difference between
the plots is not that US mortality changed at the end of 1999, but instead that the sampling schemes
for the 1980-1999 data and the 2000-2003 data were different. The 1980-1999 data consists of ages
of supercentenarians who died in this interval, while the 2000-2003 data consists of supercentenarians
who were alive at the end of 1999 but died before the middle of 2003. The effects of the 1980-1999
sampling scheme are discussed below. The 2000-2003 sampling scheme leads to two kinds of biases:
persons who have longer lives are more likely to be alive at any given point of time, say December 31,
1999, but on the other hand, persons with very long life are not included in the data set because they
have not died before the middle of 2003. These effects are different from those caused by the 1880-1999
sampling scheme, see below. Simulations confirmed that these sampling schemes can produce qq-plots
like those in Fig. 5. A further illustration of the importance of taking the sampling scheme for the
IDL data into account is given by Figure 1.
In principle, the bias caused by the different sampling scheme used for the USA 2000-2003 data
could be taken into account, and also this part of the data could be used. However, the information
given about the sampling plan for IDL supercentenarians who died in the USA after 1999 was not
sufficient to make it possible for us to do this. Hence, supercentenarians who died in the USA after
December 31, 1999, have been excluded from the analysis. For similar reasons, supercentenarians who
died in Japan in 1996, or after August 31, 2003, have also been excluded from the analysis.
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Figure 5: llustration of effect of size-biased sampling: Left: Exponential qq-plot for IDL life lengths
of supercentenarians who died 1980-1999 in USA. Right: Exponential qq-plot for IDL life lengths of
supercentenarians who died 2000-2003 in USA.
Additionally, for reasons of confidentiality, for US supercentenarians only the year of death, and
not the exact death date, is given. In the analysis we assumed that all US supercentenarian deaths
occurred on July 2. However, conclusions didn’t change if we instead set the death dates to January
1, or to December 31.
If the sampling scheme is that a cohort, all persons who are born in some time interval, is followed
until all persons in it are dead, then there is no bias in the observed ages. Similarly, if a population is
stable and there are no trends in the probability of becoming a supercentenarian, then recorded ages
of supercentenarians who died in some time interval, say 1980-1999, are not subject to bias. However,
the IDL database does not follow cohorts until they are extinct, and the probability of living until
age 110 is increasing with time. This increase, if not taken into account, would lead to bias in the
estimation of life length from the IDL data: small excess life lengths are less likely to be included in
the beginning of the interval but more likely to be included in the end of the interval – and there are
more deaths in the end. In the estimates and test performed here, we have taken this into account by
letting the likelihood contribution from a person be conditional on the time of achieving age 110 and
of death date being contained in the observation interval, as follows.
Suppose that a sample consists of all supercentenarian deaths in some country during the time
interval (b, e). Let {ti} be the times of achieving age 110 and {xi} be the corresponding excess
ages at death. Further suppose that excess life lengths have cumulative distribution function F and
probability density function f , where in our analysis F is either a GP distribution function or an
exponential distribution function. Then supercentenarian i is included in the sample if one of the
following two conditions are satisfied: if a) ti ≤ b and b ≤ ti + xi < e or if b) ti > b and ti + xi < e.
In the case a) the excess life length of supercentenarian i is truncated so that it only is included
in the sample if b − ti ≤ xi < e − ti. Hence the likelihood contribution from the excess life length of
a supercentenarian in the sample whose 110 year birthday was before the beginning of the sampling
time interval, i.e. with ti ≤ b, is
f(xi)
F (e− ti)− F (b− ti) ,
In case b) where the 110 year birthday occurred after the beginning of the sampling interval, ti > b,
the excess life length is truncated to so that xi ≤ ei − ti, and the likelihood contribution from
supercentenarian i is
f(xi)
F (e− ti) .
The full likelihood is then obtained by taking the product of the likelihood contributions for all
supercentenarians and countries included in an analysis.
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Table 2: p-values for likelihood ratio tests of no difference in mortality between women and men after
age 110. Middle column assumes GP distribution, right column exponential distribution.
ID GP exp
North Europe 0.94 0.81
South Europe 0.14 0.40
Europe 0.57 0.63
North America 0.72 0.56
Japan 0.77 0.76
Europe&America 0.42 0.43
World 0.43 0.41
Table 3: p-values for Wald tests of no difference in mortality between first and last half of data.
“mean” is the estimated parameter of the exponential distribution, not the mean of the observed life
lengths; tests assume an exponential distribution.
ID death date # mean death date # mean p-value
North Europe 1970-1997 41 1.78 1998-2006 43 1.45 0.49
South Europe 1973-1997 50 1.61 1998-2007 64 1.19 0.26
Europe 1968-1997 91 1.70 1998-2007 107 1.29 0.18
North America 1962-1992 141 1.17 1993-2002 159 1.14 0.73
Japan 1996-2000 28 2.71 2001-2005 36 1.28 0.30
Europe&America 1962-1994 242 1.34 1995-2008 251 1.21 0.33
World 1962-1996 309 1.30 1997-2008 260 1.20 0.33
Table 4: p-values for likelihood ratio tests of no difference in mortality between groups of countries.
Middle column assumes GP distribution, right column exponential distribution. A “-” means that the
test for exponential distribution of data rejects at the 1% level for the GRG data set. GP distribution
fits later part of GRG data badly.
ID GP exp
North Europe vs south Europe 0.30 0.48
Europe vs north America 0.24 0.23
Europe&America vs Japan 0.35 0.41
World vs GRG 0.00 -
Table 5: Estimates of shape parameter γ of the generalized Pareto distribution, with 95% asymptotic
confidence intervals in parenteses, and p-values for likelihood ratio test of the hypothesis that data
follows an exponential distribution. N/A indicates that computation of the inverse of the Hessian was
not numerically stable.
ID shape parameter p-value
North Europe 0.04 N/A 0.49
South Europe -0.04 (-0.19, 0.10) 0.19
Europe -0.03 (-0.18, 0.11) 0.52
North America -0.03 (-0.14, 0.09) 0.31
Europe&America -0.03 (-0.12, 0.06) 0.17
Japan 0.15 N/A 0.47
World -0.03 (-0.12, 0.06) 0.21
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Estimation using truncated and/or censored observations, such as the truncated observations in
the IDL database, is of central interest in survival analysis and in analysis of failure time data, see e.g.
Andersen et al. (1992) and Kalbfleish and Prentice (2002) for much more information and asymptotic
theory. However, the particular truncation setting above does not seem to be considered explicitly in
these books. Instead, the formulas are contained in Gampe (2010).
We have not corrected for selection bias in the qq-plots, and in fact, such corrections do not seem
to be available in the literature.
4 Comments on X. Dong, B. Milholland, J. Vijg, Nature 538, 257
(2016).
Fig. 6, left, reproduces Fig. 2.a of the Dong et al. (2016) Nature Letter, without the truncation of ages
to whole years, and with the yearly number of deaths of supercentenarians, nt, added. The plot is based
on IDL data for England & Wales, France, USA, and Japan. The data sets for the different countries
cover different time periods, and as a result of this the yearly number of supercentenarian deaths in
the plot varies from 0 to 42. The yearly maximum reported age at death follows the same pattern as
the number of supercentenarian deaths, and in particular the decline in the maximum recorded age at
death after 1995 follows the decline in yearly number of deaths. That the yearly maximum reported
age at death shows the same pattern as the yearly number of deaths is completely as expected: the
maximum of many lifespans is stochastically larger than the maximum of few lifespans, and hence the
maximum age is likely to be larger for years with many deaths.
The right plot in Fig. 6 instead of nt adds the mean of the maximum of nt independent exponential
variables, with parameter 1.35 estimated from these countries. This does not take truncation into
account, but still, again as expected, the mean and the regression lines agree well. Fig. 7 shows the
same plots as in Fig. 6, left, done separately for individual countries. There is no evidence of a trend
break in these plots.
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Figure 6: Yearly maximum reported age at death for supercentenarians. Combined data consisting
of England & Wales 1968-2006, France 1987-2003, USA 1980-2003, and Japan 1996-2005. Dashed
- dotted lines: blue regression lines for deaths 1968-1994, red regression line for deaths 1995-2006.
Left: Dashed line is yearly number of deaths, nt. Right: Solid line is 110 + mean of maximum of nt
exponential variables with σ = 1.35.
Thus, in conclusion, the apparent trend break in Fig. 2.a in Dong et al. (2016) is an artifact caused
by inappropriate combination of data from different time periods.
Fig. 2.b of Dong et al. (2016) adds the 2nd to 5th highest reported age at death to Fig. 2.a. The
pattern is the same as in Fig. 2.a, and the explanation is the same: inappropriate combination of data
from different time periods. Further, the statement in Dong et al. (2016) that “the annual average
age at death for these supercentenarians has not increased since 1968 (Fig. 2.c)” does not imply that
there is a limit. Again: records increase as more attempts to break them are made, even without a
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change in the underlying distribution. The conclusion “our data strongly suggest that the duration of
life is limited” in Dong et al. (2016) is based on wrong and misleading analysis.
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Figure 7: Yearly maximum reported age at death for supercentenarians. Dashed - dotted lines: blue is
regression lines for deaths 1968-1994, red regression line for deaths 1995-2006. Dashed lines are yearly
number of deaths. Top left: England &Wales, Top right: France, Bottom left: USA, and Bottom right:
Japan.
5 Discussion
The fact that data doesn’t shows any difference in survival at extreme age between women and men;
between persons with different lifestyles or genetic backgrounds; between different time periods; or
between different ages, say between 110-year-olds and 115-year-olds is surprising and remarkable and
can inform the search for demographic or biological theories of aging. In particular, the fact that
lifestyle factors which are important for survival at younger ages ceases to play a role after age 110 is
of both biological and popular interest.
Box 1 of Vaupel (2010) gives an introduction to the important explanation of mortality at high age
as resulting from a mixture of subpopulations with different frailty. Presumably the composition of
subpopulations of humans reaching 110 years of age differs, at least somewhat, between persons who
lived earlier and who lived later, or between countries. If the frailty hypothesis is correct, mortality
should then be different in at least some of the countries or in one of the time periods. However, we
did not find any such differences. This weakens the case for the frailty explanation.
A fundamental hypothesis on how we age is that “the rate at which the chance of death increases
with age for humans is a basic biological constant, very similar and perhaps invariant across individuals
and over time”, see Vaupel (2010). For mortality after 110, this would mean that the distribution of
excess life length in the future should still be exponential, but with lower yearly probability of death.
The methods developed in this paper provide an efficient way of checking if this indeed is the case:
power calculations show that an increase of 5% or more in yearly survival in a new data set of the
same size as the IDL data would be detectable.
Substantial efforts to find “a cure for aging” and in “engineering better humans” with the aim
of extending the length of human life, perhaps indefinitely, are underway, see e.g. Vijg and Campisi
(2008), Longo et al. (2015), Ha¨ggstro¨m (2016). Success of such efforts could happen either in a
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dramatic and obvious way, or gradually. In the latter case the results of this paper, together with
similar analyses of data to be collected in the future, will aid early confirmation of success of the
efforts.
Supplementary materials: LATool - a MATLAB toolbox for life length analysis which makes it
possible to obtain more detailed results and do alternative analyses. Available at www.zholud.com.
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